← FDA Drug Approvals (Drugs@FDA)

ZIEXTENZO

BLA · Biologics License Application · Sponsor: SANDOZ INC · Approved 2019-11-04

Drug application

FDA Application #
BLA761045
Application type
Biologics License Application
Brand name
ZIEXTENZO
Generic name
PEGFILGRASTIM-BMEZ
Active ingredients
PEGFILGRASTIM-BMEZ
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SANDOZ INC
Manufacturer
Sandoz Inc
First approval
2019-11-04

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown